Abiopharma

🔍 Sun Kang (Director)

Company: Amprius Technologies, Inc. (AMPX)

Report Date: 2026-08-21

Detailed Transactions and Holdings:

• Sold 62,101 shares of Common stock at $10.341 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,218,397.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
• Holds 0 shares of Common stock (Direct)
  Date: 2026-08-21 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 56,406.00 | Footnotes: F4

Footnotes:

• F1: This transaction was effected pursuant to non-discretionary, sell-to-cover arrangements mandated by the issuer to fund tax withholding obligations in connection with the vesting of restricted stock units.
• F2: The price reported in Column 4 is an average execution price. These shares were sold in multiple transactions at prices ranging from $10.10 to $10.48, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
• F3: Includes 911,688 restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock, subject to the applicable vesting schedule and conditions of each restricted stock unit.
• F4: These securities are held directly by the KANG & CECILLIA SUN FAMILY REVOCABLE TRUST, for which the reporting person and his spouse are co-trustees.